echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JNNP: The change rate of acetylcholine receptor antibody levels predicts the prognosis of myasthenia gravis

    JNNP: The change rate of acetylcholine receptor antibody levels predicts the prognosis of myasthenia gravis

    • Last Update: 2021-04-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Myasthenia gravis (MG) is an impact of their own neuromuscular junction synaptic membrane of immune diseases.


    Immune diagnosis

    The flowchart shows the process of determining the participants to be analyzed

    However, the correlation between the clinical status of individual patients and AChR-Ab levels remains unclear.


    In this study, the purpose of this article is to determine whether the newly developed rate of reduction of AChR-Ab levels (RR-AChRAb) measured before and after immunosuppressive therapy in this study reflects treatment response and predicts the prognosis of MG.


    fund

    The change in the absolute value of the acetylcholine receptor antibody level and the MG-ADL score between each measurement in the ELT classification

    The MG-ADL score showed a gradual downward trend at all time points.


    This observational study retrospectively studied the relationship between the change rate of AChR-Ab levels before and after immunosuppressive treatment in MG patients and the clinical outcome one year after treatment.


    RR-AChRAb can predict the 1-year prognosis and steroid responsiveness of MG.
    RR-AChRAb can predict the 1-year prognosis and steroid responsiveness of MG.
    KojimaY ,UzawaA ,OzawaY KojimaY Kojima UzawaA Uzawa OzawaY Ozawa , et al bmj.
    com/content/early/2021/03/25/jnnp-2020-325511" target="_blank" rel="noopener">Rate of change in acetylcholine receptor antibody levels predicts myasthenia gravis outcome Journal of Neurology, Neurosurgery & Psychiatry  Published Online First:  25 March 2021.
      Published Online First : doi:  10.
    1136/jnnp-2020-325511 doi:

    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.